Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S. Company announcement – No. 25 / 2019 Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S. Copenhagen, August 15, 2019 –...

Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019 Press Release – No. 17 / 2019   Copenhagen, August 1, 2019 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR no. 20 04 50 78) announces that it will host a conference call on August 15, 2019...

SSLJ.com Limited Interim Financial Report for the Six-month Period Ended June 30, 2018 WUHAN, China, May 29, 2019 (GLOBE NEWSWIRE) -- SSLJ.com Limited (the “Company”) (NASDAQ: YGTY). Interim report for the six months period ended June 30, 2018 Unless specified otherwise, “$” shall...